Obesity Drug News

Introduction

Abstract

These days we all suffer from information overload. To overcome this problem, the Obesity Drug News service focuses specifically on obesity, delivering the information you need in a timely, flexible and convenient format.

While only recently identified as a major health concern, obesity levels have been growing steadily and the condition threatens to rank among the biggest causes of premature death in both the industrialised and emerging economies. With few products approved worldwide for long-term treatment, and growing unmet clinical need, the treatment of obesity will present a major opportunity area for pharma companies.

For company executives, researchers and commercial managers, obesity is taking an important role in the industry' s plans; staying in touch with the latest twists and turns, however, is another matter. That is why this new online information service is essential.

Obesity Drug News provides:

• The latest news reported on pharmaceuticals in development for weight loss plus genetic/hormonal/biological discoveries regarding obesity and/or weight gain
• An easy-to-use interface that immediately takes you to the most recently updated information
• A fast and effective search facility allowing you to identify information relevant to you
• Daily or weekly email alerts that will ensure you know when new information is added
• An RSS feed facility

Every day, Espicom' s researchers and editors

• Track the companies and research organisations that are shaping the industry
• Report the latest developments in current and up and coming obesity treatments and research
• Monitor results from major conferences and meetings

Start your subscription today!

Obesity Drug News is available exclusively by subscription and provides:

• 24/7 single-user access for one year
• Regularly updated news and research archive - all full text
• An easy-to-use interface and full search function
• Daily/weekly email alerts
• Cost-effective multi-user distribution deals means the service can be used widely by colleagues in your organisation

Obesity Drug News published by Espicom Business Intelligence. This newsletter price starts from US $ 690.